HIV Diagnostics Test Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


Market Overview:

HIV Diagnostics tests are medical devices and reagents used to detect the presence of HIV antibodies or antigens in serum, saliva, or urine. These include immunoassays, nucleic acid tests, and rapid point-of-care tests. Early detection is important for effective treatment and management of the disease.

The global HIV Diagnostics Test Market is estimated to be valued at US$ 4,263.62 Mn in 2023 and is expected to exhibit a CAGR of 9.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. 

Get more insights on this topic: https://www.coherentmarketinsights.com/market-insight/hiv-diagnostics-market-422

Market key trends: 

One of the major trends in the HIV Diagnostics Test Market is the increasing adoption of Point-of-Care (POC) and Rapid Diagnostic Tests (RDTs). These easy-to-use tests can detect HIV within 30 minutes without any special equipment or facilities. They are very convenient for preliminary screening in decentralized healthcare settings. Manufacturers are focusing on developing more accurate and affordable POC tests to expand testing, especially in developing regions. This is expected to drive the market growth during the forecast period.

Segment Analysis

The global HIV diagnostics test market is segmented into tests, end users, and region. Based on test, the market is segmented into antibody tests, viral load tests, CD4 count tests, early infant diagnosis tests, and screening tests. Among these, the antibody tests segment dominated the market in 2022 due to rising adoption of fourth generation antibody tests by laboratories performing HIV diagnosis. Based on end users, the market is divided into diagnostics laboratories, hospitals, blood banks, home care settings, and others. The diagnostics laboratories segment accounted for the largest share of the market in 2022 owing to increased use of advanced HIV diagnosis technologies by diagnostic laboratories. 

Key Takeaways

The global HIV diagnostics test market is expected to witness high growth, exhibiting CAGR of 9.0% over the forecast period, due to increasing awareness regarding early diagnosis of HIV. 

Regional analysis: North America dominates the global market for HIV diagnostics testing. However, Asia Pacific is expected to witness the highest CAGR during the forecast period owing to improving healthcare infrastructure and increasing penetration of advanced diagnostic technologies in emerging countries such as India and China.

Key players analysis: Key players operating in the HIV diagnostics test market are Abbott, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol –Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd. These players are focusing on launching innovative and advanced HIV diagnostic products to increase their market share.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

The Where and the How: Unraveling Biology's Spatial Enigma with Omics

-
Image
In the fast-evolving landscape of biomedical research, a revolutionary technique has emerged that promises to unlock new dimensions of understanding within cellular landscapes – Spatial Omics. This cutting-edge approach combines the power of genomics, transcriptomics, proteomics, and more, with spatial information, creating a holistic view of biological systems. At its core, Spatial Omics involves mapping the molecular composition of tissues with spatial context. Traditional omics techniques provide valuable insights into the molecules present in a sample, but they lack the crucial information about where these molecules are located within the tissue. Spatial Omics bridges this gap by preserving the spatial architecture, offering unprecedented insights into cellular interactions, organization, and function. Read More @   https://www.digitaljournal.com/pr/news/coherent-market-insights/spatial-omics-market-revenue-growth-rate-customer-needs-trend-manufacturers-and-forecast-to-2030-10...
Read more

Fertility And Pregnancy Rapid Test Kits Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-
Image
The global Fertility And Pregnancy Rapid Test Kits Market is estimated to be valued at US$ 1,451.9 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.  Market Overview:  Pregnancy Rapid Test kits help in early detection of pregnancy in women. They are easy-to-usekits providing quick results within 5-10 minutes without laboratory or medical assistance.  Market key trends:  One of the key trends driving growth in the fertility and pregnancy rapid test kits market is increasing demand for home use pregnancy and ovulation prediction test kits. Manufacturers are focusing on making test kits more affordable and convenient for home use without medical supervision. Portable personal fertility monitors that track various fertility signs like cervical mucus, basal body temperature, etc on a mobile app are gaining popularity. The increasing use of digital technology in ...
Read more